 |
Sarbanes-Oxley News & Developments
Bristol-Myers to Pay $150 Million in SEC SettlementCharges alleged the pharmaceutical giant inflated sales and earnings to fool investors.
> > On the heel of last week $300-million class-action-suit settlement, the drug maker agreed to pay a super-sized fine to erase accounting fraud allegations.
Source: CFO
Published:2004-08-10
|
|